Janus Henderson Group
VNDA icon

Janus Henderson Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Janus Henderson Group’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,887
Closed -$107K – 2613
2023
Q3 		$107K Buy
24,887
+5
+0% +$28 ﹤0.01% 2508
2023
Q2 		$164K Sell
24,882
-26
-0.1% -$167 ﹤0.01% 2497
2023
Q1 		$169K Buy
24,908
+13,762
+123% +$96.8K ﹤0.01% 2535
2022
Q4 		$82.3K Sell
11,146
-11,146
-50% -$109K ﹤0.01% 2363
2022
Q3 		$220K Buy
22,292
+11,162
+100% +$118K ﹤0.01% 2362
2022
Q2 		$122K Sell
11,130
-30,943
-74% -$321K ﹤0.01% 2439
2022
Q1 		$476K Buy
42,073
+30,937
+278% +$407K ﹤0.01% 1953
2021
Q4 		$175K Buy
+11,136
New +$194K ﹤0.01% 2429
2021
Q1 		– Sell
-77,171
Closed -$1.01M – 1634
2020
Q4 		$1.01M Buy
77,171
+7,511
+11% +$90.4K ﹤0.01% 1201
2020
Q3 		$673K Buy
69,660
+6,554
+10% +$70.1K ﹤0.01% 1187
2020
Q2 		$722K Buy
63,106
+30,237
+92% +$342K ﹤0.01% 1153
2020
Q1 		$341K Buy
+32,869
New +$408K ﹤0.01% 1216

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Janus Henderson Group's VNDA Position: Q4 2023 in Review

Janus Henderson Group sold out of Vanda Pharmaceuticals (VNDA) in Q4 2023, closing a stake of 24,887 shares — an estimated $107K sold.

Janus Henderson Group first reported a position in VNDA in Q1 2020 and held it in 12 quarters. The position peaked at $1.01M in Q4 2020. 157 funds tracked by Wall St. Rank hold VNDA as of Q4 2023.

  • Janus Henderson Group reported no remaining Vanda Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Janus Henderson Group sold 24,887 Vanda Pharmaceuticals shares in Q4 2023, an estimated $107K.
  • Janus Henderson Group first reported a position in Vanda Pharmaceuticals in Q1 2020 and held it in 12 quarters.
  • Janus Henderson Group's Vanda Pharmaceuticals position peaked at $1.01M in Q4 2020.
  • 157 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.